Evaluation of Long-term Efficacy of Treatment With Lamazym
NCT02478840
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
Alpha-Mannosidosis
Interventions
DRUG:
Lamazym
Sponsor
Zymenex A/S